Related Experiment Video
Updated: Jul 15, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Association of FHR5 With Disease Severity in ANCA-Associated Vasculitis
Yan-Jie Li1,2,3,4,5,6, Su-Fang Chen1,2,3,4,5,6, Zhi-Ying Li1,2,3,4,5,5
1Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
Elevated levels and deposition of FH-related protein 5 (FHR5) in ANCA-associated vasculitis (AAV) correlate with severe kidney damage. Glomerular FHR5 deposition independently predicts end-stage kidney disease (ESKD) in AAV patients.
Area of Science:
- Nephrology
- Immunology
- Complement System
Background:
- Alternative complement pathway activation is key in ANCA-associated vasculitis (AAV) pathogenesis.
- Complement factor H (FH) plays a crucial role in AAV.
- FH-related protein 5 (FHR5) antagonizes FH activity.
Purpose of the Study:
- To investigate the association between FHR5 and disease severity in AAV.
- To determine the relationship between FHR5 and renal outcomes in AAV patients.
Main Methods:
- Retrospective cohort study of 154 active AAV patients and 55 in remission.
- Plasma FHR5 levels measured by ELISA.
- Renal FHR5 deposition assessed by immunohistochemistry (IHC).
Main Results:
- Higher plasma FHR5 in active AAV than remission/controls, correlating with inflammation and renal damage.
- Glomerular FHR5 deposition found in 69% of kidney biopsies.
- Moderate/strong FHR5 deposition linked to worse renal function, injury, and treatment response.
Conclusions:
- Elevated plasma and glomerular FHR5 are associated with active AAV and severe kidney damage.
- Glomerular FHR5 deposition is an independent risk factor for end-stage kidney disease (ESKD) in AAV.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies